The Supreme Court on Monday said that telemedicine access to the abortion drug mifepristone can stay — for at least a week. But as mifepristone faces court challenges, another drug that remains ...

Novo Nordisk has launched the first oral Ozempic pill in the United States for adults with type 2 diabetes, approved to reduce blood sugar levels and cardiovascular risks. Available in multiple ...

Ozempic tablets will launch nationwide on May 4, 2026, offering a reformulated and smaller pill for type 2 diabetes and cardiovascular risk management.

Ozempic oral pill will be produced entirely in the US and distributed through more than 70,000 pharmacies in the US.

The NHS could save tens of thousands of pounds per patient each year by prescribing tablets instead of liquid medicine to children with a particular medical condition, experts have revealed.

The NHS could start giving children tablets instead of liquid medicine and save millions of pounds, research suggests. Pills cost a fraction of the cost and switching to them could save the health ...

The Moto Pad will be available in the US starting on April 30th, while the new Moto G Stylus launches on April 16th. The Moto Pad will be available in the US starting on April 30th, while the new Moto ...

Much to the relief of the needle-shy, the Food and Drug Administration has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug ...

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...